首页 | 本学科首页   官方微博 | 高级检索  
检索        

恩度联合化疗治疗多种恶性复发肿瘤转移灶的疗效观察
引用本文:章骏,赵怡,杨志刚,曹伟.恩度联合化疗治疗多种恶性复发肿瘤转移灶的疗效观察[J].实用癌症杂志,2011,26(1):69-70.
作者姓名:章骏  赵怡  杨志刚  曹伟
作者单位:上海市杨浦区市东医院肿瘤外科,200438
摘    要:目的观察重组人血管内皮抑制素(恩度)联合化疗方案对多种恶性复发肿瘤转移灶的疗效及安全性。方法经病理组织学或细胞学检查确诊的晚期复发恶性肿瘤患者6例,均接受恩度联合化疗的方案治疗。按照RESIST标准评价近期疗效,参照KPS评分评价生活质量,按照NCICTC3.0版标准评价不良反应。结果在6例观察的患者中,PR 1例,CR 3例,SD 2例,RR为66.7%(4/6),CBR为100.0%(6/6),未发现与恩度相关的严重不良反应。结论恩度联合化疗的方案对治疗恶性肿瘤患者的复发和转移具有良好的疗效,同时没有明显增加化疗的不良反应,值得进一步推广。

关 键 词:晚期肿瘤  重组人血管内皮抑制素  复发转移

Effects of Endostar Combination with Chemotherapy for the Treatment of the Metastasis of Various Recurrences Malignant Tumor
ZHANG Jun,ZHAO Yi,YANG Zhi-gang,et al..Effects of Endostar Combination with Chemotherapy for the Treatment of the Metastasis of Various Recurrences Malignant Tumor[J].The Practical Journal of Cancer,2011,26(1):69-70.
Authors:ZHANG Jun  ZHAO Yi  YANG Zhi-gang  
Institution:ZHANG Jun,ZHAO Yi,YANG Zhi-gang,et al.Department of Surgical Oncology,Shidong Hospital,Shanghai,200438
Abstract:Objective To observe the effects and safety of recombinant human endostatin(Endostar) combination with chemotherapy for the treatment of the metastasis of recurrence malignant tumor.Methods 6 patients with pathologically or cytologically confirmed recurrent or metastatic malignant tumors were treated with Endostar combined with chemotherapy.The treatment results were evaluated according to the RESIST criteria.The KPS scores were used to evaluate the quality of life,and the NCICTC 3.0 was used to evaluate th...
Keywords:Advanced cancer  Recombinant human endostatin  Recurrence and metastasis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号